Question: I have read a lot of articles on your website about new treatments for alopecia areata that are being developed. My son has alopecia universalis so I am keen to help him find a cure. Could you tell me how long it takes for these treatments to become available? Thank you.
Answer: Hi, Judith. We cannot give you a precise figure as obviously this varies on a case-by-case basis. However, we can tell you that it is generally reported that the period it takes from development through to a new pharmaceutical drug becoming available to consumers is estimated at 8 to 12 years.
This is assuming the drug successfully completes all stages of the necessary clinical trials to ensure the product is safe and effective for long-term use.
It is so important to have what may seem like a long, drawn-out process in place as, whilst some drugs may flourish in the early stages of testing, or in small-scale tests, many treatments do not pass all of these mandatory, stringent criteria.
There are a number of treatments for alopecia universalis in development at the moment which appear promising, most notably tofacitinib citrate. However, their long-term suitability and safety will not be truly known until they have been consistently proven over the requisite period.
We are keeping a close eye on the latest developments in treatments for all causes of hair loss and will continue to report on the most significant as soon as information becomes available.
The Belgravia Centre is an organisation specialising in hair growth and hair loss prevention with two clinics and in-house pharmacies in Central London, UK. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the world. View our Hair Loss Success Stories, which includes the world’s largest gallery of hair growth comparison photos and demonstrates the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time to arrange a free consultation.